Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients

BACKGROUND AND AIMS: Interferon beta (IFNb) is a safe first-line drug commonly used for relapsing-remitting (RR)-MS. Nevertheless, a considerable proportion of patients do not respond to IFNb treatment. Therefore, until now, a number of studies have investigated various markers that could predict th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Neurol Disord
Main Authors: Stampanoni Bassi, Mario, Drulovic, Jelena, Pekmezovic, Tatjana, Iezzi, Ennio, Sica, Francesco, Gilio, Luana, Gentile, Antonietta, Musella, Alessandra, Mandolesi, Georgia, Furlan, Roberto, Finardi, Annamaria, Marfia, Girolama Alessandra, Bellantonio, Paolo, Fantozzi, Roberta, Centonze, Diego, Buttari, Fabio
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7727083/
https://ncbi.nlm.nih.gov/pubmed/33343708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286420970833
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados